🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/12/2003 | 10,23 | 10,28 | 9,97 | 10,25 | +1,69% | 3,03% | 391.800 |
| 09/12/2003 | 10,45 | 10,47 | 10,00 | 10,08 | -2,94% | 4,45% | 305.600 |
| 08/12/2003 | 9,95 | 10,50 | 9,95 | 10,38 | +2,77% | 5,53% | 600.600 |
| 05/12/2003 | 10,13 | 10,33 | 9,98 | 10,10 | -1,37% | 3,41% | 397.200 |
| 04/12/2003 | 10,00 | 10,30 | 10,00 | 10,24 | +1,99% | 2,95% | 479.800 |
| 03/12/2003 | 10,11 | 10,45 | 10,02 | 10,04 | +0,25% | 4,26% | 465.400 |
| 02/12/2003 | 9,79 | 10,43 | 9,71 | 10,02 | +1,88% | 7,41% | 1.359.000 |
| 01/12/2003 | 9,38 | 9,98 | 9,38 | 9,83 | +4,46% | 6,40% | 730.200 |
| 28/11/2003 | 9,68 | 9,68 | 9,27 | 9,41 | -1,72% | 4,19% | 311.000 |
| 26/11/2003 | 9,48 | 9,66 | 9,43 | 9,58 | +1,97% | 2,48% | 321.400 |
| 25/11/2003 | 9,28 | 9,50 | 9,28 | 9,39 | +1,51% | 2,42% | 995.800 |
| 24/11/2003 | 9,29 | 9,35 | 9,23 | 9,25 | +1,15% | 1,35% | 966.000 |
| 21/11/2003 | 9,24 | 9,40 | 9,11 | 9,15 | -0,92% | 3,14% | 1.055.000 |
| 20/11/2003 | 9,31 | 9,61 | 9,19 | 9,23 | -0,81% | 4,51% | 395.400 |
| 19/11/2003 | 9,21 | 9,47 | 9,13 | 9,31 | +1,14% | 3,69% | 537.000 |
| 18/11/2003 | 9,43 | 9,51 | 9,20 | 9,20 | -1,97% | 3,23% | 740.200 |
| 17/11/2003 | 9,53 | 9,53 | 9,33 | 9,39 | -2,29% | 2,10% | 630.600 |
| 14/11/2003 | 10,17 | 10,18 | 9,47 | 9,61 | -5,14% | 6,98% | 555.000 |
| 13/11/2003 | 10,11 | 10,18 | 9,92 | 10,13 | +0,35% | 2,57% | 306.000 |
| 12/11/2003 | 9,60 | 10,11 | 9,54 | 10,09 | +5,27% | 5,94% | 363.600 |
| 11/11/2003 | 9,73 | 9,84 | 9,50 | 9,59 | -1,79% | 3,49% | 503.400 |
| 10/11/2003 | 10,04 | 10,14 | 9,74 | 9,76 | -3,27% | 3,99% | 530.600 |
| 07/11/2003 | 9,98 | 10,38 | 9,98 | 10,09 | +0,60% | 4,01% | 522.400 |
| 06/11/2003 | 10,04 | 10,35 | 9,88 | 10,03 | -1,67% | 4,68% | 1.876.000 |
| 05/11/2003 | 10,19 | 10,28 | 9,95 | 10,20 | +0,25% | 3,24% | 487.000 |
| 04/11/2003 | 10,10 | 10,30 | 10,09 | 10,18 | +0,84% | 2,08% | 467.800 |
| 03/11/2003 | 10,17 | 10,38 | 10,07 | 10,09 | +0,25% | 3,00% | 886.200 |
| 31/10/2003 | 10,06 | 10,17 | 9,89 | 10,07 | +1,41% | 2,73% | 714.600 |
| 30/10/2003 | 9,85 | 10,06 | 9,78 | 9,93 | +2,32% | 2,89% | 1.372.800 |
| 29/10/2003 | 9,75 | 9,88 | 9,27 | 9,70 | -2,22% | 6,26% | 2.644.400 |